Tara R. Hawkinson

Tara R. Hawkinson

Auto-generated profile, based on publicly available information

Tara R. Hawkinson

Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, Gainesville, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
HCHarrison A. Clarke
Harrison A. Clarke
XMXin Ma
Xin Ma
CSCameron J. Shedlock
Cameron J. Shedlock
TMTerrymar Medina
Terrymar Medina
THTara R. Hawkinson
Tara R. Hawkinson
RSramon sun
ramon sun
Metabolites, lipids, and glycans are fundamental but interconnected classes of biomolecules that form the basis of the metabolic network. These molecules are dynamically channeled through multiple pathways that govern cellular physiology and pathology. Here, we present a framework for the simultaneous spatial analysis of the metabolome, lipidome, and glycome from a single tissue section using mass spectrometry imaging. This workflow integrates a computational platform, the Spatial Augmented Multiomics Interface (Sami), which enables multiomics integration, high-dimensional clustering, spatial anatomical mapping of matched molecular features, and metabolic pathway enrichment. To demonstrate the utility of this approach, we applied Sami to evaluate metabolic diversity across distinct brain regions and to compare wild-type and Ps19 Alzheimer’s disease (AD) mouse models. Our findings reveal region-specific metabolic demands in the normal brain and highlight metabolic dysregulation in the Ps19 model, providing insights into the biochemical alterations associated with neurodegeneration.

5 September 2022 in EMBO Molecular Medicine
Verified
Journal Article
Open access
LYLyndsay E A Young
Lyndsay E A Young
LCLindsey R Conroy
Lindsey R Conroy
HCHarrison A Clarke
Harrison A Clarke
THTara R Hawkinson
Tara R Hawkinson
KBKayli Bolton
Kayli Bolton
MGMatthew Gentry
Matthew Gentry
Glycogen dysregulation is a hallmark of aging, and aberrant glycogen drives metabolic reprogramming and pathogenesis in multiple diseases. However, glycogen heterogeneity in healthy and diseased tissues remains largely unknown. Herein, we describe a method to define spatial glycogen architecture in mouse and human tissues using matrix‐assisted laser desorption/ionization mass spectrometry imaging. This assay provides robust and sensitive spatial glycogen quantification and architecture characterization in the brain, liver, kidney, testis, lung, bladder, and even the bone. Armed with this tool, we interrogated glycogen spatial distribution and architecture in different types of human cancers. We demonstrate that glycogen stores and architecture are heterogeneous among diseases. Additionally, we observe unique hyperphosphorylated glycogen accumulation in Ewing sarcoma, a pediatric bone cancer. Using preclinical models, we correct glycogen hyperphosphorylation in Ewing sarcoma through genetic and pharmacological interventions that ablate in vivo tumor growth, demonstrating the clinical therapeutic potential of targeting glycogen in Ewing sarcoma.

11 March 2025 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
HCHarrison A. Clarke
Harrison A. Clarke
THTara R. Hawkinson
Tara R. Hawkinson
CSCameron J. Shedlock
Cameron J. Shedlock
TMTerrymar Medina
Terrymar Medina
RRRoberto A. Ribas
Roberto A. Ribas
RSramon sun
ramon sun

18 March 2025 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
XMXin Ma
Xin Ma
CSCameron J. Shedlock
Cameron J. Shedlock
TMTerrymar Medina
Terrymar Medina
RRRoberto A. Ribas
Roberto A. Ribas
HCHarrison A. Clarke
Harrison A. Clarke
RSramon sun
ramon sun

9 June 2026 in Nature Metabolism
Verified
Journal Article
Open access
THTara R. Hawkinson
Tara R. Hawkinson
ZLZizhen Liu
Zizhen Liu
RRRoberto A. Ribas
Roberto A. Ribas
TMTerrymar Medina
Terrymar Medina
RNRikke S. Nielsen
Rikke S. Nielsen
RSramon sun
ramon sun
Alzheimer's disease (AD) is a devastating neurodegenerative disorder marked by progressive cognitive decline. Metabolic disruptions are widely observed, yet their involvement in the molecular aetiology of AD remains underexplored. Here we identify hyperglycosylation as a driver of AD. Integrating spatial metabolomics, lipidomics and glycomics in transgenic AD mouse models and post-mortem human AD samples, along with advanced spatial isotopic tracing pulse-chase analysis of N-linked glycans, we demonstrate that the conserved phenotype of brain hyperglycosylation is driven by increased glycan biosynthesis. Genetic knockdown of glycan biosynthetic enzymes improves cognitive outcomes in AD mice whereas oral glucosamine supplementation impairs them. A retrospective analysis of electronic health records from patients with AD with varying disease severity shows that glucosamine supplementation is associated with accelerated AD progression and worsened survival. Overall, these results establish hyperglycosylation as a pathological driver of AD and highlight glycan metabolism as an actionable target in the fight against AD.

2 September 2023 in Neuropsychopharmacology
Verified
Journal Article
Closed access
PDF file
MXMengfan Xia
Mengfan Xia
TATanner L. Anderson
Tanner L. Anderson
EPEmily R. Prantzalos
Emily R. Prantzalos
THTara R. Hawkinson
Tara R. Hawkinson
HCHarrison A. Clarke
Harrison A. Clarke
POPavel I. Ortinski
Pavel I. Ortinski